These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34146935)

  • 21. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging.
    Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y
    J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of Chitosan and its Derivatives in Nanocarrier Based Pulmonary Drug Delivery Systems.
    Dua K; Bebawy M; Awasthi R; Tekade RK; Tekade M; Gupta G; De Jesus Andreoli Pinto T; Hansbro PM
    Pharm Nanotechnol; 2017; 5(4):243-249. PubMed ID: 28786352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ellagic acid-loaded, tween 80-coated, chitosan nanoparticles as a promising therapeutic approach against breast cancer: In-vitro and in-vivo study.
    Kaur H; Ghosh S; Kumar P; Basu B; Nagpal K
    Life Sci; 2021 Nov; 284():119927. PubMed ID: 34492262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bufalin loaded biotinylated chitosan nanoparticles: an efficient drug delivery system for targeted chemotherapy against breast carcinoma.
    Tian X; Yin H; Zhang S; Luo Y; Xu K; Ma P; Sui C; Meng F; Liu Y; Jiang Y; Fang J
    Eur J Pharm Biopharm; 2014 Aug; 87(3):445-53. PubMed ID: 24846793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced delivery of Paclitaxel using electrostatically-conjugated Herceptin-bearing PEI/PLGA nanoparticles against HER-positive breast cancer cells.
    Yu K; Zhao J; Zhang Z; Gao Y; Zhou Y; Teng L; Li Y
    Int J Pharm; 2016 Jan; 497(1-2):78-87. PubMed ID: 26617314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effect of quercetin and pH-responsive DEAE-chitosan carriers as drug delivery system for breast cancer treatment.
    de Oliveira Pedro R; Goycoolea FM; Pereira S; Schmitt CC; Neumann MG
    Int J Biol Macromol; 2018 Jan; 106():579-586. PubMed ID: 28807690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation of Piperine-Chitosan-Coated Liposomes: Characterization and In Vitro Cytotoxic Evaluation.
    Imam SS; Alshehri S; Altamimi MA; Hussain A; Qamar W; Gilani SJ; Zafar A; Alruwaili NK; Alanazi S; Almutairy BK
    Molecules; 2021 May; 26(11):. PubMed ID: 34072306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, In Silico Modelling, and Functionality Theory of Novel Folate Receptor Targeted Rutin Encapsulated Folic Acid Conjugated Keratin Nanoparticles for Effective Cancer Treatment.
    Kunjiappan S; Panneerselvam T; Govindaraj S; Parasuraman P; Baskararaj S; Sankaranarayanan M; Arunachalam S; Babkiewicz E; Jeyakumar A; Lakshmanan M
    Anticancer Agents Med Chem; 2019; 19(16):1966-1982. PubMed ID: 31267878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microfluidics-assisted conjugation of chitosan-coated polymeric nanoparticles with antibodies: Significance in drug release, uptake, and cytotoxicity in breast cancer cells.
    Escareño N; Hassan N; Kogan MJ; Juárez J; Topete A; Daneri-Navarro A
    J Colloid Interface Sci; 2021 Jun; 591():440-450. PubMed ID: 33631531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer.
    Yadav AS; Radharani NNV; Gorain M; Bulbule A; Shetti D; Roy G; Baby T; Kundu GC
    Nanoscale; 2020 May; 12(19):10664-10684. PubMed ID: 32374338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-assembled amphiphilic chitosan nanoparticles for quercetin delivery to breast cancer cells.
    de Oliveira Pedro R; Hoffmann S; Pereira S; Goycoolea FM; Schmitt CC; Neumann MG
    Eur J Pharm Biopharm; 2018 Oct; 131():203-210. PubMed ID: 30145220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ATP/Hyals dually responsive core-shell hyaluronan/chitosan-based drug nanocarrier for potential application in breast cancer therapy.
    Li H; Zhuang S; Yang Y; Zhou F; Rong J; Zhao J
    Int J Biol Macromol; 2021 Jul; 183():839-851. PubMed ID: 33965490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel multi-targeted nanoparticles for targeted co-delivery of nucleic acid and chemotherapeutic agents to breast cancer tissues.
    Amani A; Alizadeh MR; Yaghoubi H; Nohtani M
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111494. PubMed ID: 33255061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and in vitro study of modified chitosan-polycaprolactam nanocomplex as delivery system.
    Rezvani M; Mohammadnejad J; Narmani A; Bidaki K
    Int J Biol Macromol; 2018 Jul; 113():1287-1293. PubMed ID: 29481956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted delivery of doxorubicin to breast cancer cells by magnetic LHRH chitosan bioconjugated nanoparticles.
    Varshosaz J; Hassanzadeh F; Aliabadi HS; Khoraskani FR; Mirian M; Behdadfar B
    Int J Biol Macromol; 2016 Dec; 93(Pt A):1192-1205. PubMed ID: 27693338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physicochemical characterization of chitosan-hyaluronan-coated solid lipid nanoparticles for the targeted delivery of paclitaxel: a proof-of-concept study in breast cancer cells.
    Campos J; Varas-Godoy M; Haidar ZS
    Nanomedicine (Lond); 2017 Mar; 12(5):473-490. PubMed ID: 28181464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific targeting delivery to MUC1 overexpressing tumors by albumin-chitosan nanoparticles conjugated to DNA aptamer.
    Esfandyari-Manesh M; Mohammadi A; Atyabi F; Nabavi SM; Ebrahimi SM; Shahmoradi E; Varnamkhasti BS; Ghahremani MH; Dinarvand R
    Int J Pharm; 2016 Dec; 515(1-2):607-615. PubMed ID: 27989825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin.
    Li L; Jiang G; Yu W; Liu D; Chen H; Liu Y; Tong Z; Kong X; Yao J
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):278-286. PubMed ID: 27770892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin drug delivery by vanillin-chitosan coated with calcium ferrite hybrid nanoparticles as carrier.
    Kamaraj S; Palanisamy UM; Kadhar Mohamed MSB; Gangasalam A; Maria GA; Kandasamy R
    Eur J Pharm Sci; 2018 Apr; 116():48-60. PubMed ID: 29355595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A self-targeting and controllable drug delivery system constituting mesoporous silica nanoparticles fabricated with a multi-stimuli responsive chitosan-based thin film layer.
    Chen C; Yao W; Sun W; Guo T; Lv H; Wang X; Ying H; Wang Y; Wang P
    Int J Biol Macromol; 2019 Feb; 122():1090-1099. PubMed ID: 30219514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.